Loading...
Loading...
NEW YORK, NY · CIK 0001263508
Portfolio Value
$23.07B
Positions
127
New
12
Increased
23
Decreased
15
Sold Out
12
BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $23.07B across 127 positions in their Q1 2021 SEC 13F filing (period ending 2021-03-31). The top 10 positions account for 80.5% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | SGENUSDSeagen Inc. | $6.56B | 28.46% | +0.0% |
| 2 | ONCBeiGene, Ltd. | $4.06B | 17.61% | - |
| 3 | INCYIncyte Corporation | $2.60B | 11.28% | +0.0% |
| 4 | KODKodiak Sciences Inc. | $1.57B | 6.82% | - |
| 5 | ACADACADIA Pharmaceuticals Inc. | $1.08B | 4.69% | +0.0% |
| 6 | ALXNAlexion Pharmaceuticals, Inc. | $610.62M | 2.65% | -54.4% |
| 7 | NVTA1EURInvitae Corporation | $601.78M | 2.61% | +0.6% |
| 8 | BMRNBioMarin Pharmaceutical Inc. | $573.07M | 2.48% | - |
| 9 | ASNDUSDAscendis Pharma A/S | $456.27M | 1.98% | - |
| 10 | PRLDPrelude Therapeutics Incorporated | $438.67M | 1.90% | +0.1% |
| Stock | Value | Shares |
|---|---|---|
| IMCRImmunocore Holdings plc | $107.31M | 2,520,730 |
| TILInstil Bio, Inc. | $97.65M | 3,893,700 |
| Talis Biomedical Corporation | $97.34M | 7,574,835 |
| DSGNDesign Therapeutics, Inc. | $42.95M | 1,436,636 |
| 698Achilles Therapeutics plc | $42.89M | 2,591,366 |
| OTICEUROtonomy, Inc. | $18.41M | 7,220,074 |
| EWTXEdgewise Therapeutics, Inc. | $16.25M | 500,000 |
| SRPT 1.5 11/15/24Sarepta Therapeutics, Inc. | $11.97M | 9,174,000 |
| RVMDRevolution Medicines, Inc. | $10.20M | 222,222 |
| NEXI1EURNexImmune, Inc. | $5.61M | 294,117 |
Get alerts when BAKER BROS. ADVISORS LP files new 13F holdings.